Generally speaking, it is preferred to use liposomes having a small size, less than 100 nanometers in diameter, desirably about 25 to about 75 nanometers in diameter
Together, you can review your goals, risks, and preferences to decide on the most appropriate treatment path
In the LEADER trial, liraglutide demonstrated cardiovascular benefit, and GLP1RAs have similar effects, aligning with liraglutides anti-atherosclerotic effect
Instead of jumping doses weekly, many prescribers extend the timeline to two to three weeks per dose step, allowing your cardiovascular system to stabilize
Study design ATTAIN-MAINTAIN enrolled participants who had already completed 72 weeks of treatment with the highest tolerated doses of either semaglutide (Wegovy) or tirzepatide (Zepbound) as part of the SURMOUNT-5 trial
B12 Shots for Non-Deficient Individuals (i.e